GPX4 and non-small cell lung carcinoma: Meanwhile, the results indicated that GPX4 activities of NSCLC cell lines (A549, HCC827, and two cell lines NCI-H1299 and NCI-H661 with high expression of GPX4) treated with AFC (1 mg/ml) were significantly reduced, compared to them on control group (Figure S1).